000 01393 a2200409 4500
005 20250512055625.0
264 0 _c19860724
008 198607s 0 0 eng d
022 _a0025-6196
024 7 _a10.1016/s0025-6196(12)62007-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSterioff, S
245 0 0 _aCurrent status of renal transplantation--1986.
_h[electronic resource]
260 _bMayo Clinic proceedings
_cJul 1986
300 _a573-8 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntilymphocyte Serum
_xtherapeutic use
650 0 4 _aCadaver
650 0 4 _aDiabetes Mellitus, Type 1
_xcomplications
650 0 4 _aDrug Therapy, Combination
650 0 4 _aGraft Rejection
_xdrug effects
650 0 4 _aHLA Antigens
_xanalysis
650 0 4 _aHLA-DR Antigens
650 0 4 _aHistocompatibility Antigens Class II
_xanalysis
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xadministration & dosage
650 0 4 _aKidney
_ximmunology
650 0 4 _aKidney Failure, Chronic
_xsurgery
650 0 4 _aKidney Transplantation
650 0 4 _aMiddle Aged
650 0 4 _aReoperation
650 0 4 _aTissue Donors
700 1 _aEngen, D E
700 1 _aZincke, H
773 0 _tMayo Clinic proceedings
_gvol. 61
_gno. 7
_gp. 573-8
856 4 0 _uhttps://doi.org/10.1016/s0025-6196(12)62007-2
_zAvailable from publisher's website
999 _c3525894
_d3525894